dc.contributor.author | Vojkovics, Dóra | |
dc.contributor.author | Kellermayer, Zoltán | |
dc.contributor.author | Kajtár, Béla | |
dc.contributor.author | Roncador, Giovanna | |
dc.contributor.author | Vincze, Áron | |
dc.contributor.author | Balogh, Péter | |
dc.date.accessioned | 2019-09-26T10:19:52Z | |
dc.date.available | 2019-09-26T10:19:52Z | |
dc.date.issued | 2018-02-06 | |
dc.identifier.citation | Biomark Insights. 2018;13:1177271918757480 | es_ES |
dc.identifier.issn | 1177-2719 | es_ES |
dc.identifier.uri | http://hdl.handle.net/20.500.12105/8383 | |
dc.description.abstract | The development of peripheral lymphoid tissues from the mesoderm is the result of a complex convergence combining lymphohematopoietic differentiation with the local specification of nonhematopoietic mesenchymal components. Although the various transcriptional regulators with fate-determining effects in diversifying the mobile leukocyte subsets have been thoroughly studied and identified, the tissue-specific determinants promoting the regional differentiation of resident mesenchyme are less understood. Of these factors, various members of the NK-class Nkx paralogues have emerged as key regulators for the organogenesis of spleen and mucosal lymphoid tissues, and recent data have also indicated their involvement in various pathological events, including gut inflammation and hematopoietic malignancies. Here, we summarize available data on the roles of Nkx2-3 in lymphoid tissue development and discuss its possible value as a developmental marker and disease-associated pathogenic trait. | es_ES |
dc.description.sponsorship | The author(s) disclosed receipt of the following financial support for the research, authorship, and/or publication of this article: Z.K. is supported by the ÚNKP-17-4-I New National Excellence Program of the Ministry of Human Capacities and the postdoctoral research grant of the Faculty of Medicine, University of Pécs. This work was supported by OTKA K108429, GINOP-232-15-2016-00050, and EFOP-361-16-2016-
00004 research funds. | es_ES |
dc.language.iso | eng | es_ES |
dc.publisher | Frontiers Media | es_ES |
dc.type.hasVersion | VoR | es_ES |
dc.rights.uri | http://creativecommons.org/licenses/by-nc-sa/4.0/ | * |
dc.subject | Nkx2-3 | es_ES |
dc.subject | inflammation | es_ES |
dc.subject | lymphoid organs | es_ES |
dc.subject | lymphoma | es_ES |
dc.title | Nkx2-3-A Slippery Slope From Development Through Inflammation Toward Hematopoietic Malignancies | es_ES |
dc.type | journal article | es_ES |
dc.rights.license | Atribución-NoComercial-CompartirIgual 4.0 Internacional | * |
dc.identifier.pubmedID | 29449776 | es_ES |
dc.format.volume | 13 | es_ES |
dc.format.page | 1177271918757480 | es_ES |
dc.identifier.doi | 10.1177/1177271918757480 | es_ES |
dc.contributor.funder | Ministerio de Economía y Competitividad (España) | |
dc.description.peerreviewed | Sí | es_ES |
dc.relation.publisherversion | https://doi.org/10.1177/1177271918757480. | es_ES |
dc.identifier.journal | Biomarker insights | es_ES |
dc.repisalud.institucion | CNIO | es_ES |
dc.repisalud.orgCNIO | CNIO::Unidades técnicas::Unidad de Anticuerpos Monoclonales | es_ES |
dc.relation.projectID | info:eu-repo/grantAgreement/ES/FFI2016-78034-C2-2-P | es_ES |
dc.rights.accessRights | open access | es_ES |